Ophthotech Reports Third Quarter 2018 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Wall St set for higher open after Micron revives AI optimism, upbeat economic data
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
Ophthotech Corp (OPHT) Tops Q3 EPS by 2c
October 31, 2018 6:42 AM EDTOphthotech Corp (NASDAQ: OPHT) reported Q3 EPS of ($0.41), $0.02 better than the analyst estimate of ($0.43).
During 2018 Ophthotech made significant progress in bringing together a diversified pipeline of therapeutic and gene therapy programs for the treatment of retinal diseases, stated Glenn P. Sblendorio, Chief Executive Officer... More
